8-K Announcements
6Material company update
May 28, 2026·SEC
Material company update
May 22, 2026·SEC
Material company update
May 18, 2026·SEC
FOXO Technologies Inc.(FOXO)Earnings, Financials & Key Ratios
FOXO•AMEX
$0.00
Price updated Jul 2, 2026
AboutFOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in Minneapolis, Minnesota.Show more
- Revenue$16M+304.0%
- EBITDA-$10M-49.1%
- Net Income-$12M-0.2%
- EPS (Diluted)-0.13+86.0%
- Gross Margin49.12%+27.0%
- EBITDA Margin-59.46%+63.1%
- Operating Margin-63.11%+67.1%
- Net Margin-75.94%+75.2%
- ROE-152.07%+35.4%
FOXO Price & Volume
FOXO Technologies Inc. (FOXO) stock price & volume — 10-year historical chart
Loading chart...
Persistent Liquidity Constraints Threaten Operational Continuity
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity crisis
Key Thesis Takeaways
- FOXO Technologies faces a precarious financial outlook characterized by extreme revenue volatility and a failure to achieve consistent operating leverage, as evidenced by a -63.11% historical operating margin.
- The company's reliance on intangible assets, with $27.8 million in goodwill representing over 60% of total assets, combined with a severe liquidity shortfall, suggests significant risk to long-term shareholder value.
- Investors should remain cautious as the firm struggles to bridge the gap between its experimental epigenetic testing model and a sustainable, cash-generative commercial operation.
Verdict Logic
the company's acute liquidity crisis, highlighted by a current ratio of 0.14 and a cash balance of just $65,900, presents an imminent risk of insolvency that outweighs potential growth prospects.
FOXO Growth Metrics
FOXO Technologies Inc. (FOXO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years204.04%
3 Years217.58%
TTM154.57%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-15.17%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-3.01%
Return on Capital
10 Years-317.43%
5 Years-361.1%
3 Years-155.85%
Last Year-82.97%
FOXO Recent Earnings
FOXO Technologies Inc. (FOXO) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.00
—
Rev
$5M
—
Q2 2026
Apr 15, 2026Metric
Actual
Est
EPS
$0.01
—
Rev
$4M
—
Q4 2025
Nov 17, 2025Metric
Actual
Est
EPS
$0.04
—
Rev
$4M
—
Q3 2025
Aug 22, 2025Metric
Actual
Est
EPS
$0.23
—
Rev
$5M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.00 | $5M |
| Q2 2026 | Apr 15, 2026 | $0.01 | $4M |
| Q4 2025 | Nov 17, 2025 | $0.04 | $4M |
| Q3 2025 | Aug 22, 2025 | $0.23 | $5M |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for FOXO Technologies Inc. (FOXO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.00 | $311.25K | -0.00 | 303.98% | -75.94% | -152.07% | — | |
| $0.31 | $8.94M | -0.02 | -54.71% | -189.73% | -462.09% | — | |
| $0.89 | $156.3M | 66.66 | 15.5% | 4.45% | 12.16% | — | |
| $314.74 | $686.21M | 12.71 | 8.92% | 22.1% | 10.76% | — | |
| $69.33 | $5.33B | -30.14 | 40.15% | -16.92% | -26.52% | — | |
| $60.01 | $841.09M | 26.79 | 28.95% | 3.7% | 15.88% | — |
Compare FOXO vs Peers
FOXO Technologies Inc. (FOXO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
FOXO SEC Filings & Documents
FOXO Technologies Inc. (FOXO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when FOXO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
FOXO Frequently Asked Questions
FOXO Technologies Inc. (FOXO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is FOXO Technologies Inc.'s revenue?
FOXO Technologies Inc. (FOXO) reported $18.4M in revenue for fiscal year 2025. This represents a 29052% increase from $0.1M in 2020.
How fast is FOXO Technologies Inc. growing?
FOXO Technologies Inc. (FOXO) grew revenue by 304.0% over the past year. This is strong growth.
Is FOXO profitable?
FOXO Technologies Inc. (FOXO) reported a net loss of $13.3M for fiscal year 2025.
Dividend & Returns
What is FOXO's return on equity?
FOXO Technologies Inc. (FOXO) has a return on equity (ROE) of -152.1%. Negative ROE indicates the company is unprofitable.
What is FOXO Technologies Inc.'s free cash flow?
FOXO Technologies Inc. (FOXO) had negative free cash flow of $2.5M in fiscal year 2025, likely due to heavy capital investments.